Skip to content

Net margin at other companies

Baxter International logo
Baxter InternationalBAX
-9.7%+62.5pp
PTH
Pelthos Therapeutics Inc.PTHS
-186.2%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
121.5%+103pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-125.9%-54.5pp
RFL
Rafael Holdings, Inc.RFL
-2,117.2%-517pp
Opko Health logo
Opko HealthOPK
-36.6%-44.8pp

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+142%
Enterprise value$90.91M+212%
P/S2.3×+1.4×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Calculated from Cumberland Pharmaceuticals’s reported figures.

Based on trailing twelve months.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's net margin?
Cumberland Pharmaceuticals (CPIX) reported net margin of -17.6% in Q1 2026.
How has Cumberland Pharmaceuticals's net margin changed year-over-year?
Cumberland Pharmaceuticals's net margin decreased by 120.7% year-over-year, from -8% to -17.6%.
What is the long-term trend for Cumberland Pharmaceuticals's net margin?
Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's net margin has grown at a -6.5% compound annual growth rate (CAGR), from -8.9% to -6.4%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.